OpenURL Connection Search

Select item for more details and to access through your institution.

Monocytes Exposed to Immune Complexes Reduce pDC Type 1 Interferon Response to Vidutolimod.
Published in:
Vaccines, 2021, v. 9, n. 9, p. 982, doi. 10.3390/vaccines9090982
By:
- Sabree, Shakoora A.;
- Lemke-Miltner, Caitlin D.;
- Blackwell, Sue E.;
- Yin, Chaobo;
- Bossler, Aaron;
- Ebeid, Kareem;
- Salem, Aliasger K.;
- Weiner, George J.
Publication type:
Article
B-CLL cells acquire APC- and CTL-like phenotypic characteristics after stimulation with CpG ODN and IL-21.
Published in:
International Immunology, 2014, v. 26, n. 7, p. 383, doi. 10.1093/intimm/dxu001
By:
- Hagn, Magdalena;
- Blackwell, Sue E.;
- Beyer, Thamara;
- Ebel, Verena;
- Fabricius, Dorit;
- Lindner, Stefanie;
- Stilgenbauer, Stefan;
- Simmet, Thomas;
- Tam, Constantine;
- Neeson, Paul;
- Trapani, Joseph A.;
- Schrezenmeier, Hubert;
- Weiner, George J.;
- Jahrsdörfer, Bernd
Publication type:
Article
CpG oligodeoxynucleotides enhance FcγRI-mediated cross presentation by dendritic cells.
Published in:
International Immunology, 2004, v. 16, n. 8, p. 1091, doi. 10.1093/intimm/dxh110
By:
- Lisette Bevaart;
- Heidi H. Van Ojik;
- Amanda W. Sun;
- Timothy H. Sulahian;
- Jeanette H. W. Leusen;
- George J. Weiner;
- Jan G. J. van de Winkel;
- Martine J. Van Vugt
Publication type:
Article
Anti-CD3-based bispecific antibody designed for therapy of human B-cell malignancy can induce T-cell activation by antigen-dependent and antigen-independent mechanisms.
Published in:
International Journal of Cancer, 1998, v. 77, n. 2, p. 251, doi. 10.1002/(SICI)1097-0215(19980717)77:2<251::AID-IJC14>3.0.CO;2-E
By:
- Link, Brian K.;
- Kostelny, Sheri A.;
- Cole, Michael S.;
- Fusselman, William P.;
- Tso, J. Yun;
- Weiner, George J.
Publication type:
Article
Intraperitoneal CMP-001: A Novel Immunotherapy for Treating Peritoneal Carcinomatosis of Gastrointestinal and Pancreaticobiliary Cancer.
Published in:
Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2021, v. 28, n. 2, p. 1187, doi. 10.1245/s10434-020-08591-7
By:
- Miller, Ann M.;
- Lemke-Miltner, Caitlin D.;
- Blackwell, Sue;
- Tomanek-Chalkley, Ann;
- Gibson-Corely, Katherine N.;
- Coleman, Kristen L.;
- Weiner, George J.;
- Chan, Carlos H. F.
Publication type:
Article
The Lymphoma Epidemiology of Outcomes cohort study: Design, baseline characteristics, and early outcomes.
Published in:
American Journal of Hematology, 2024, v. 99, n. 3, p. 408, doi. 10.1002/ajh.27202
By:
- Cerhan, James R.;
- Maurer, Matthew J.;
- Link, Brian K.;
- Feldman, Andrew L.;
- Habermann, Thomas M.;
- Jaye, David L.;
- Burack, W. Richard;
- McDonnell, Timothy J.;
- Vega, Francisco;
- Chapman, Jennifer R.;
- Syrbu, Sergei;
- Vij, Kiran R.;
- Inghirami, Giorgio;
- Leonard, John P.;
- Bernal‐Mizrachi, Leon;
- Farooq, Umar;
- Witzig, Thomas E.;
- Weiner, George J.;
- Wang, Yucai;
- Alderuccio, Juan P.
Publication type:
Article
The kinetics and dynamics of responses to placebo*.
Published in:
Clinical Pharmacology & Therapeutics, 1996, v. 60, n. 3, p. 247, doi. 10.1016/S0009-9236(96)90051-X
By:
- Weiner, Murray;
- Weiner, George J.
Publication type:
Article
T cells, particularly activated CD4+ cells, maintain anti-CD20-mediated NK cell viability and antibody dependent cellular cytotoxicity.
Published in:
Cancer Immunology, Immunotherapy, 2022, v. 71, n. 2, p. 237, doi. 10.1007/s00262-021-02976-7
By:
- Wang, Zhaoming;
- Chimenti, Michael S.;
- Strouse, Christopher;
- Weiner, George J.
Publication type:
Article
Immunostimulatory CpG oligonucleotides enhance the immune response of anti-idiotype vaccine that mimics carcinoembryonic antigen.
Published in:
Cancer Immunology, Immunotherapy, 2003, v. 52, n. 5, p. 317, doi. 10.1007/s00262-002-0351-x
By:
- Baral, Rathindra Nath;
- Saha, Asim;
- Chatterjee, Sunil K.;
- Foon, Kenneth A.;
- Krieg, Arthur M.;
- Weiner, George J.;
- Bhattacharya-Chatterjee, Malaya
Publication type:
Article
The T Cell Immunoscore as a Reference for Biomarker Development Utilizing Real-World Data from Patients with Advanced Malignancies Treated with Immune Checkpoint Inhibitors †.
Published in:
Cancers, 2023, v. 15, n. 20, p. 4913, doi. 10.3390/cancers15204913
By:
- Eljilany, Islam;
- Saghand, Payman Ghasemi;
- Chen, James;
- Ratan, Aakrosh;
- McCarter, Martin;
- Carpten, John;
- Colman, Howard;
- Ikeguchi, Alexandra P.;
- Puzanov, Igor;
- Arnold, Susanne;
- Churchman, Michelle;
- Hwu, Patrick;
- Conejo-Garcia, Jose;
- Dalton, William S.;
- Weiner, George J.;
- El Naqa, Issam M.;
- Tarhini, Ahmad A.
Publication type:
Article
Quantification of Receptor Occupancy by Ligand—An Understudied Class of Potential Biomarkers.
Published in:
Cancers, 2020, v. 12, n. 10, p. 2956, doi. 10.3390/cancers12102956
By:
- Veeramani, Suresh;
- Weiner, George J.
Publication type:
Article
ANTI-LYMPHOMA MONOCLONAL ANTIBODIES: MAKING BETTER ANTIBODIES AND MAKING ANTIBODIES BETTER.
Published in:
Transactions of the American Clinical & Climatological Association, 2015, v. 126, p. 87
By:
- WEINER, GEORGE J.
Publication type:
Article
Prospective correlation between the patient microbiome with response to and development of immune-mediated adverse effects to immunotherapy in lung cancer.
Published in:
2021
By:
- Chau, Justin;
- Yadav, Meeta;
- Liu, Ben;
- Furqan, Muhammad;
- Dai, Qun;
- Shahi, Shailesh;
- Gupta, Arnav;
- Mercer, Keri Nace;
- Eastman, Evan;
- Hejleh, Taher Abu;
- Chan, Carlos;
- Weiner, George J.;
- Cherwin, Catherine;
- Lee, Sonny T. M.;
- Zhong, Cuncong;
- Mangalam, Ashutosh;
- Zhang, Jun
Publication type:
journal article
Manipulation of cellular redox parameters for improving therapeutic responses in B-cell lymphoma and multiple myeloma.
Published in:
Journal of Cellular Biochemistry, 2012, v. 113, n. 2, p. 419, doi. 10.1002/jcb.23387
By:
- Goel, Apollina;
- Spitz, Douglas R.;
- Weiner, George J.
Publication type:
Article
Humanization and characterization of the anti-HLA-DR antibody 1D10.
Published in:
International Journal of Cancer, 2001, v. 93, n. 4, p. 556, doi. 10.1002/ijc.1366
By:
- Kostelny, Sheri A.;
- Link, Brian K.;
- Tso, J. Yun;
- Vasquez, Max;
- Jorgensen, Brett H.;
- Wang, Hong;
- Hall, William C.;
- Weiner, George J.
Publication type:
Article
The anti-tumor effects of cetuximab in combination with VTX-2337 are T cell dependent.
Published in:
Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-020-80957-z
By:
- Cheng, Yinwen;
- Borcherding, Nicholas;
- Ogunsakin, Ayomide;
- Lemke-Miltner, Caitlin D.;
- Gibson-Corley, Katherine N.;
- Rajan, Anand;
- Choi, Allen B.;
- Wongpattaraworakul, Wattawan;
- Chan, Carlos H. F.;
- Salem, Aliasger K.;
- Weiner, George J.;
- Simons, Andrean L.
Publication type:
Article
Immune checkpoint markers and anti‐CD20‐mediated NK cell activation.
Published in:
Journal of Leukocyte Biology, 2021, v. 110, n. 4, p. 723, doi. 10.1002/JLB.5A0620-365R
By:
- Wang, Zhaoming;
- Weiner, George J.
Publication type:
Article
Early event status informs subsequent outcome in newly diagnosed follicular lymphoma.
Published in:
American Journal of Hematology, 2016, v. 91, n. 11, p. 1096, doi. 10.1002/ajh.24492
By:
- Maurer, Matthew J.;
- Bachy, Emmanuel;
- Ghesquières, Hervé;
- Ansell, Stephen M.;
- Nowakowski, Grzegorz S.;
- Thompson, Carrie A.;
- Inwards, David J.;
- Allmer, Cristine;
- Chassagne-Clément, Catherine;
- Nicolas-Virelizier, Emmanuelle;
- Sebban, Catherine;
- Lebras, Laure;
- Sarkozy, Clementine;
- Macon, William R.;
- Feldman, Andrew L.;
- Syrbu, Sergei I.;
- Traverse-Glehan, Alexandra;
- Coiffier, Bertrand;
- Slager, Susan L.;
- Weiner, George J.
Publication type:
Article
Elevated soluble IL-2 Rα, IL-8, and MIP-1β levels are associated with inferior outcome and are independent of MIPI score in patients with mantle cell lymphoma.
Published in:
American Journal of Hematology, 2014, v. 89, n. 12, p. E223, doi. 10.1002/ajh.23838
By:
- Sonbol, Mohamad B.;
- Maurer, Matthew J.;
- Stenson, Mary J.;
- Allmer, Cristine;
- LaPlant, Betsy R.;
- Weiner, George J.;
- Macon, William R.;
- Cerhan, James R.;
- Witzig, Thomas E.;
- Gupta, Mamta
Publication type:
Article
Chemoimmunotherapy for relapsed/refractory and progressive 17p13-deleted chronic lymphocytic leukemia (CLL) combining pentostatin, alemtuzumab, and low-dose rituximab is effective and tolerable and limits loss of CD20 expression by circulating CLL cells.
Published in:
American Journal of Hematology, 2014, v. 89, n. 7, p. 757, doi. 10.1002/ajh.23737
By:
- Zent, Clive S.;
- Taylor, Ronald P.;
- Lindorfer, Margaret A.;
- Beum, Paul V.;
- LaPlant, Betsy;
- Wu, Wenting;
- Call, Timothy G.;
- Bowen, Deborah A.;
- Conte, Michael J.;
- Frederick, Lori A.;
- Link, Brian K.;
- Blackwell, Sue E.;
- Veeramani, Suresh;
- Baig, Nisar A.;
- Viswanatha, David S.;
- Weiner, George J.;
- Witzig, Thomas E.
Publication type:
Article
A phase I trial of immunostimulatory CpG 7909 oligodeoxynucleotide and 90yttrium ibritumomab tiuxetan radioimmunotherapy for relapsed B-cell non-Hodgkin lymphoma.
Published in:
American Journal of Hematology, 2013, v. 88, n. 7, p. 589, doi. 10.1002/ajh.23460
By:
- Witzig, Thomas E.;
- Wiseman, Gregory A.;
- Maurer, Matthew J.;
- Habermann, Thomas M.;
- Micallef, Ivana N.M.;
- Nowakowski, Grzegorz S.;
- Ansell, Stephen M.;
- Colgan, Joseph P.;
- Inwards, David J.;
- Porrata, Luis F.;
- Link, Brian K.;
- Zent, Clive S.;
- Johnston, Patrick B.;
- Shanafelt, Tait D.;
- Allmer, Cristine;
- Asmann, Yan W.;
- Gupta, Mamta;
- Ballas, Zuhair K.;
- Smith, Brian J.;
- Weiner, George J.
Publication type:
Article
Germline variation in complement genes and event-free survival in follicular and diffuse large B-cell lymphoma.
Published in:
American Journal of Hematology, 2012, v. 87, n. 9, p. 880, doi. 10.1002/ajh.23273
By:
- Charbonneau, Bridget;
- Maurer, Matthew J.;
- Fredericksen, Zachary S.;
- Zent, Clive S.;
- Link, Brian K.;
- Novak, Anne J.;
- Ansell, Stephen M.;
- Weiner, George J.;
- Wang, Alice H.;
- Witzig, Thomas E.;
- Dogan, Ahmet;
- Slager, Susan L.;
- Habermann, Thomas M.;
- Cerhan, James R.
Publication type:
Article
Elevated serum free light chains are associated with inferior event free and overall survival in Hodgkin lymphoma.
Published in:
American Journal of Hematology, 2011, v. 86, n. 12, p. 998, doi. 10.1002/ajh.22168
By:
- Thompson, Carrie A.;
- Maurer, Matthew J.;
- Cerhan, James R.;
- Katzmann, Jerry A.;
- Ansell, Stephen M.;
- Habermann, Thomas M.;
- Macon, William R.;
- Weiner, George J.;
- Link, Brian K.;
- Witzig, Thomas E.
Publication type:
Article
Persistent thrombocytopenia during remission in acute leukemia does not preclude long-term disease-free survival.
Published in:
American Journal of Hematology, 2002, v. 71, n. 3, p. 236, doi. 10.1002/ajh.10219
By:
- Heckman, Kevin D.;
- Weiner, George J.;
- Burns, C. Patrick
Publication type:
Article
275. Immunostimulatory Antigen Loaded Microparticles as Cancer Vaccines.
Published in:
Molecular Therapy, 2006, v. 13, p. S105, doi. 10.1016/j.ymthe.2006.08.329
By:
- Salem, Aliasger K.;
- Sandler, Anthony D.;
- Weiner, George J.;
- Xueqing Zhang;
- Baman, Nicki K.;
- Xiaoyan Zhu;
- Dahle, Christopher E.
Publication type:
Article
The pattern of clinical breast cancer metastasis correlates with a single nucleotide polymorphism in the C1qA component of complement.
Published in:
Immunogenetics, 2006, v. 58, n. 1, p. 1, doi. 10.1007/s00251-005-0077-y
By:
- Racila, Emilian;
- Racila, Doina M.;
- Ritchie, Justine M.;
- Taylor, Christiana;
- Dahle, Christopher;
- Weiner, George J.
Publication type:
Article
Academic Cancer Center Phase I Program Development.
Published in:
Oncologist, 2017, v. 22, n. 4, p. 369, doi. 10.1634/theoncologist.2016-0409
By:
- Frankel, Arthur E.;
- Flaherty, Keith T.;
- Weiner, George J.;
- Chen, Robert;
- Azad, Nilofer S.;
- Pishvaian, Michael J.;
- Thompson, John A.;
- Taylor, Matthew H.;
- Mahadevan, Daruka;
- Lockhart, A. Craig;
- Vaishampayan, Ulka N.;
- Berlin, Jordan D.;
- Smith, David C.;
- Sarantopoulos, John;
- Riese, Matthew;
- Saleh, Mansoor N.;
- Ahn, Chul;
- Frenkel, Eugene P.
Publication type:
Article
Cohort Profile: The Lymphoma Specialized Program of Research Excellence (SPORE) Molecular Epidemiology Resource (MER) Cohort Study.
Published in:
2017
By:
- Cerhan, James R.;
- Link, Brian K.;
- Habermann, Thomas M.;
- Maurer, Matthew J.;
- Feldman, Andrew L.;
- Syrbu, Sergei I.;
- Thompson, Carrie A.;
- Farooq, Umar;
- Novak, Anne J.;
- Slager, Susan L.;
- Allmer, Cristine;
- Lunde, Julianne J.;
- Macon, William R.;
- Inwards, David J.;
- Johnston, Patrick B.;
- Micallef, Ivana N. M.;
- Nowakowski, Grzegorz S.;
- Ansell, Stephen M.;
- Kay, Neil E.;
- Weiner, George J.
Publication type:
journal article
Bispecific antibody-activated T cells enhance NK cell-mediated antibody-dependent cellular cytotoxicity.
Published in:
Journal of Hematology & Oncology, 2021, v. 14, n. 1, p. 1, doi. 10.1186/s13045-021-01216-w
By:
- Wang, Zhaoming;
- Yin, Chaobo;
- Lum, Lawrence G.;
- Simons, Andrean;
- Weiner, George J.
Publication type:
Article
Building better monoclonal antibody-based therapeutics.
Published in:
Nature Reviews Cancer, 2015, v. 15, n. 6, p. 361, doi. 10.1038/nrc3930
By:
- Weiner, George J.
Publication type:
Article
Building better monoclonal antibody-based therapeutics.
Published in:
2015
By:
- Weiner, George J
Publication type:
journal article

Found: 31

Monocytes Exposed to Immune Complexes Reduce pDC Type 1 Interferon Response to Vidutolimod.

B-CLL cells acquire APC- and CTL-like phenotypic characteristics after stimulation with CpG ODN and IL-21.

CpG oligodeoxynucleotides enhance FcγRI-mediated cross presentation by dendritic cells.

Anti-CD3-based bispecific antibody designed for therapy of human B-cell malignancy can induce T-cell activation by antigen-dependent and antigen-independent mechanisms.

Intraperitoneal CMP-001: A Novel Immunotherapy for Treating Peritoneal Carcinomatosis of Gastrointestinal and Pancreaticobiliary Cancer.

The Lymphoma Epidemiology of Outcomes cohort study: Design, baseline characteristics, and early outcomes.

The kinetics and dynamics of responses to placebo<sup>*</sup>.

T cells, particularly activated CD4<sup>+</sup> cells, maintain anti-CD20-mediated NK cell viability and antibody dependent cellular cytotoxicity.

Immunostimulatory CpG oligonucleotides enhance the immune response of anti-idiotype vaccine that mimics carcinoembryonic antigen.

The T Cell Immunoscore as a Reference for Biomarker Development Utilizing Real-World Data from Patients with Advanced Malignancies Treated with Immune Checkpoint Inhibitors †.

Quantification of Receptor Occupancy by Ligand—An Understudied Class of Potential Biomarkers.

ANTI-LYMPHOMA MONOCLONAL ANTIBODIES: MAKING BETTER ANTIBODIES AND MAKING ANTIBODIES BETTER.

Prospective correlation between the patient microbiome with response to and development of immune-mediated adverse effects to immunotherapy in lung cancer.

Manipulation of cellular redox parameters for improving therapeutic responses in B-cell lymphoma and multiple myeloma.

Humanization and characterization of the anti-HLA-DR antibody 1D10.

The anti-tumor effects of cetuximab in combination with VTX-2337 are T cell dependent.

Immune checkpoint markers and anti‐CD20‐mediated NK cell activation.

Early event status informs subsequent outcome in newly diagnosed follicular lymphoma.

Elevated soluble IL-2 Rα, IL-8, and MIP-1β levels are associated with inferior outcome and are independent of MIPI score in patients with mantle cell lymphoma.

Chemoimmunotherapy for relapsed/refractory and progressive 17p13-deleted chronic lymphocytic leukemia (CLL) combining pentostatin, alemtuzumab, and low-dose rituximab is effective and tolerable and limits loss of CD20 expression by circulating CLL cells.

A phase I trial of immunostimulatory CpG 7909 oligodeoxynucleotide and <sup>90</sup>yttrium ibritumomab tiuxetan radioimmunotherapy for relapsed B-cell non-Hodgkin lymphoma.

Germline variation in complement genes and event-free survival in follicular and diffuse large B-cell lymphoma.

Elevated serum free light chains are associated with inferior event free and overall survival in Hodgkin lymphoma.

Persistent thrombocytopenia during remission in acute leukemia does not preclude long-term disease-free survival.

275. Immunostimulatory Antigen Loaded Microparticles as Cancer Vaccines.

The pattern of clinical breast cancer metastasis correlates with a single nucleotide polymorphism in the C1qA component of complement.

Academic Cancer Center Phase I Program Development.

Cohort Profile: The Lymphoma Specialized Program of Research Excellence (SPORE) Molecular Epidemiology Resource (MER) Cohort Study.

Bispecific antibody-activated T cells enhance NK cell-mediated antibody-dependent cellular cytotoxicity.

Building better monoclonal antibody-based therapeutics.

Building better monoclonal antibody-based therapeutics.